BioLineRx Market Cap

BioLineRx has a market cap or net worth of $13.16 million as of February 5, 2025. Its market cap has decreased by -88.02% in one year.

Market Cap

13.16M

Enterprise Value

13.62M

1-Year Change

-88.02%

Ranking

#5010

Market Cap Chart

Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $13.16M, a decrease of -61.06%. That is a compound annual growth rate of -5.89%.

Market Cap History

Date	Market Cap	% Change
Feb 4, 2025	13.16M	-43.96%
Dec 31, 2024	23.49M	-79.62%
Dec 31, 2023	115.26M	305.33%
Dec 29, 2022	28.44M	-71.41%
Dec 30, 2021	99.46M	66.19%
Dec 31, 2020	59.85M	124.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	743.82B
UnitedHealth Group	501.97B
Johnson & Johnson	369.55B
Novo Nordisk	366.04B
AbbVie	335.67B
Merck & Co.	229.54B
Abbott Laboratories	223.92B
Thermo Fisher Scientific	222.07B

Market Cap Rankings